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Galectins are an evolutionarily conserved family of proteins that translate
glycan recognition into cellular effects. Galectin-11 is a unique member of the
galectin family that is only expressed in ruminants such as sheep, goat and cattle
and that plays a critical role in several important biological processes, such as
reproduction and parasite-mediated innate immune responses. Currently, these
two areas are of major importance for the sustainability of ruminant livestock
production. Despite the emerging biological significance of galectin-11, no
structural information is available. It is expected that structural studies will
unravel the functional mechanisms of galectin-11 activity. Here, the expression,
purification and crystallization of the ruminant-specific galectin-11 from
domestic sheep and the collection of X-ray data to 2.0 A˚ resolution are reported.
1. Introduction
The sustainability of ruminant livestock production is being
threatened by several factors, including climate change,
disease control and reproductive success (Singh et al., 2012).
Considerable research has led to the identification of several
proteins that play important roles in immune responses and
reproductive processes. One such protein is termed galectin-11
and belongs to the evolutionarily conserved galectin family
that modulates various cellular communications, cell adhesion
and pathogen recognition (Vasta, 2012). Galectins are char-
acterized by the presence of a conserved carbohydrate-
recognition domain (CRD) and exhibit a preference towards
-galactosides. While other galectins appear to be highly
conserved in all higher vertebrates, galectin-11 has only been
found in ruminants such as sheep, goats and cattle (Dunphy
et al., 2000). Galectin-11 has the predicted CRD as well as
LDV and RGD recognition sequences for proposed integrin
binding (Farmer et al., 2008). Integrins recognize the RGD and
LDV motifs within ligands such as galectin-11 and the binding
mediates various cell processes (D’Souza et al., 1991). Integrin
binding by galectin-11 in the uterus is important for trophec-
toderm cell migration, attachment and activation, which are
critical for proper blastocyst elongation and implantation
(Farmer et al., 2008). Apart from reproduction, galectin-11
also has a proposed role in immune responses against para-
sites (Meeusen et al., 2005). Expression of galectin-11 in the
abomasal mucosa leads to the development of a mucosal
microenvironment that discourages parastic larval establish-
ment in the abomasal crypts (Jackson et al., 2004). It has been
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proposed that galectin-11 changes the mucosal micro-
environment by increasing the viscosity via carbohydrate
binding (Meeusen et al., 2005). In spite of the emerging
biological significance of galectin-11 in livestock production,
no structural study on this protein has been reported. This lack
of structural knowledge has hampered research efforts in the
development of galectin-11 for the treatment of parasitic
diseases or for increasing reproductive success. Here, we
report our progress on the expression, purification and preli-
minary crystallographic study of galectin-11.
2. Materials and methods
2.1. Macromolecule production
2.1.1. Cloning. The Ovis aries galectin-11-encoding
sequence was amplified using cDNA prepared from sheep
abomasum tissue by polymerase chain reaction (PCR) with
galectin-specific primers (Table 1) using Phusion High-Fidelity
DNA polymerase (New England Biolabs). The galectin-11
gene was cloned into a modified pET-28 vector (Luna-Vargas
et al., 2011), giving a protein with an HRV 3C-cleavable
N-terminal hexahistidine tag using a ligation-independent
cloning method as described in Doyle (2005) (Table 1). The
ligated plasmid was transformed into Escherichia coli XL-1
Blue cells and plated onto a Luria–Bertani (LB) agar plate
containing kanamycin (50 mg ml1). The clone obtained was
confirmed by DNA sequencing.
2.1.2. Recombinant protein production of galectin-11.
Recombinant protein expression of full-length galectin-11
(encoding amino acids 1–140; galectin-111–140) was performed
in the BL21 (DE3) E. coli strain (Table 1). A starter culture
was grown from a single colony overnight in 100 ml LB
medium containing kanamycin (50 mg ml1). The starter
culture was used at 1:100 dilution to inoculate 800 ml fresh LB
medium containing 50 mg ml1 kanamycin and grown at 310 K
until the OD600 reached 0.6. Expression of galectin-11
1–140 was
induced with 0.5 mM IPTG and the cells were allowed to grow
for a further 16 h at 291 K. The cells were collected following
centrifugation at 4000g for 30 min at 277 K and were stored at
193 K.
2.1.3. Purification of recombinant protein. The frozen cell
pellet was thawed on ice and resuspended in 20 ml lysis buffer
[20 mM Tris–HCl, 150 mM NaCl, 0.1%(v/v) Triton X-100] per
gram in the presence of 0.2 mM phenylmethanesulfonyl-
fluoride. The bacterial suspension was lysed by sonication, the
cell debris was removed by centrifugation and fine particles
were filtered. The crude E. coli extract was applied onto 5 ml
nickel Sepharose beads (GE Healthcare) under native
conditions. The unbound proteins was washed with three
column volumes of wash buffer [50 mM Tris–HCl pH 8.0,
500 mM NaCl, 5%(v/v) glycerol, 30 mM imidazole] and eluted
with 15 ml elution buffer [50 mM Tris–HCl pH 8.0, 500 mM
NaCl, 5%(v/v) glycerol, 300 mM imidazole] and collected as
2 ml fractions. The eluted protein fractions were analysed by
SDS–PAGE.
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Table 1
Macromolecule-production information.
Source organism O. aries
DNA source O. aries cDNA
Forward primer 50-CAGGGACCCGGTATGGACTCCTTGCCG-30
Reverse primer 50-CGAGGAGAAGCCCGGTTATAACGTATCCACT-
30
Cloning vector pET-28 plasmid
Expression vector pET-28 plasmid
Expression host E. coli BL21 (DE3)
Complete amino-acid sequence
of the full-length construct
produced (galectin-111–140)
MAHHHHHHSAALEVLFQGPGMDSLPNPYLQSVSL-
TVCYMVKIKANLLSPFGKNPELQVDFGTGTGQ-
GGDIPFRFWYCDGIVVMNTLKDGSWGKEQKLH-
TEAFVPGQPFELQFLVLENEYQVFVNNKPICQ-
FAHRLPLQSVKMLDVRGDIVLTSVDTL
Amino-acid sequence of
crystallized galectin-11 after
HCV-3C protease treatment
(galectin-1118–140)
GPGMDSLPNPYLQSVSLTVCYMVKIKANLLSPFG-
KNPELQVDFGTGTGQGGDIPFRFWYCDGIVVM-
NTLKDGSWGKEQKLHTEAFVPGQPFELQFLVL-
ENEYQVFVNNKPICQFAHRLPLQSVKMLDVRG-
DIVLTSVDTL
Figure 1
(a) Size-exclusion chromatography trace of recombinant galectin-1118–140.
Arrows indicate the elution volumes of proteins of known molecular
weight (labelled in kDa). (b) SDS–PAGE analysis of purified protease-
treated recombinant galectin-1118–140 (lane 2). Molecular weights (lane 1)
are indicated on the left in kDa. (c) Recombinant galectin-111–140 is
shown to be functional by elution from a galactose Sepharose column
with different sugars. Lanes 2, 3, 4 and 5 show galectin-111–140 eluted from
a column with galactose, lactose, mannose and fructose, respectively. The
positions of molecular-weight markers (labelled in kDa) are shown in
lane 1.
Fractions containing galectin-111–140 were pooled and
concentrated to 5 ml using Amicon ultracentrifugal filters
(3000 kDa molecular-weight cutoff; Millipore). After the
addition of 50 mM arginine and 50 mM glutamic acid, the
purified protein fractions were concentrated to 5 mg ml1 and
the hexahistidine tag was cleaved by incubation at 277 K
overnight with HRV-3C protease in a 1:100 ratio (protease:
protein). Uncleaved protein was purified using nickel
Sepharose beads and the cleaved protein was confirmed by
Western blotting with an anti-hexahistidine antibody. The
cleaved galectin-11 (containing amino acids 18–140; galectin-
1118–140; Table 1) was further purified by size-exclusion chro-
matography with a Superdex S75 16/60 gel-filtration column
(GE Healthcare Life Sciences) equilibrated in TBS (10 mM
Tris–HCl, 125 mM NaCl, 5 mM TCEP [tris(2-carboxyethyl)-
phosphine] and 10%(v/v) glycerol using an A¨KTA Basic fast
protein liquid-chromatography (FPLC) system (Fig. 1a). The
molecular weight, purity and identity of the protease-treated
galectin-1118–140 were confirmed by SDS–PAGE (Fig. 1b),
Western blotting with anti-Gal-11 antibody (Dunphy et al.,
2000) and N-terminal sequencing. The purified protein was
concentrated to 5.0 mg ml1 and stored at 277 K for use in
crystallization trials. The concentration of galectin-1118–140 was
determined spectrophotometrically (NanoDrop 1000, Thermo
Scientific) at 280 nm and calculated using an extinction coef-
ficient of 16 960M1 cm1 as determined using the ProtParam
tool (http://web.expasy.org/protparam)
2.1.4. Sugar binding by recombinant galectin-11. To
determine whether recombinant galectin-111–140 is functional,
the following procedure was followed. 500 ml recombinant
galectin-111–140 (2.5 mg ml1) was incubated with 200 ml
galactose Sepharose (Pierce) equilibrated in sugar-binding
buffer (20 mM Tris–HCl pH 8.2, 200 mM NaCl, 5 mM
-mercaptoethanol) overnight at 277 K using an end-to-end
shaker. Unbound protein was washed with three column
volumes of sugar-binding buffer and eluted with 2 ml 1M
galactose, lactose, mannose and fructose in sugar-binding
buffer. The eluted protein was analyzed by SDS–PAGE and
Coomassie Blue staining (Fig. 1c).
2.2. Crystallization
The initial crystallization conditions of protease-treated
galectin-1118–140 (Table 1) were screened using 288 conditions
from commercially available kits from Hampton Research
(Crystal Screen, Crystal Screen 2 and PEG/Ion) and Qiagen
(The JCSG+ Suite) with a CrystalMation integrated robotic
workstation (Rigaku). Over 30 different conditions produced
crystals of galectin-1118–140 with various morphologies within
4 d. The crystals with the best morphology were obtained in
24-well Linbro plates (Hampton Research) with drops
consisting of 1 ml protein solution and 1 ml precipitant solution
and a reservoir volume of 500 ml (Fig. 2). Crystallization
information is summarized in Table 2.
2.3. Data collection and processing
Crystals were soaked for 30 s in cryoprotectant solution
consisting of 20%(v/v) glycerol, 2%(v/v) Tacsimate pH 7.0,
0.1M HEPES–HCl pH 7.5, 20%(w/v) PEG 3350 before
cooling at 100 K in a stream of nitrogen gas. A complete data
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Figure 2
Crystal of galectin-1118–140 from O. aries. The approximate dimensions of
the crystal used for data collection were 1.8 0.8 0.1 mm. The scale bar
represents 0.1 mm.
Table 2
Crystallization.
Method Hanging drop
Plate type 24-well Linbro plate
Temperature (K) 293
Protein concentration (mg ml1) 5
Buffer composition of protein
solution
10 mM Tris–HCl, 125 mM NaCl, 5 mM
TCEP, 10%(v/v) glycerol
Composition of reservoir solution 2%(v/v) Tacsimate pH 7.0, 0.1M HEPES
pH 7.5, 20%(w/v) PEG 3350
Volume and ratio of drop 1 ml protein solution:1 ml reservoir
solution
Volume of reservoir (ml) 500
Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source MX1, Australian Synchrotron
Wavelength (A˚) 0.9537
Temperature (K) 100
Detector ADSC Quantum 210r CCD
Crystal-to-detector distance (mm) 200
Rotation range per image () 0.5
Total rotation range () 180
Exposure time per image (s) 2
Space group P212121
Unit-cell parameters (A˚, ) a = 96.2, b = 127.5, c = 141.4,
 =  =  = 90.0
Resolution range (A˚) 38.86–2.00 (2.03–2.00)
Total No. of reflections 915448 (35018)
No. of unique reflections 115982 (5501)
Completeness (%) 98.6 (95.4)
hI/(I)i† 6.6 (1.9)
Rp.i.m.‡ (%) 10.8 (59.3)
Wilson B factor (A˚2) 14.26
† I is the integrated intensity and (I) is the estimated standard deviation of that
intensity. ‡ Rp.i.m. =
P
hklf1=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ,
where Ii(hkl) is the scaled intensity of the ith measurement and hI(hkl)i is the mean
intensity for that reflection.
set was collected from a single crystal on the MX1 beamline at
the Australian Synchrotron (Cowieson et al., 2015) using an
ADSC Quantum 210r CCD detector (Fig. 3). The data were
processed withMOSFLM (Leslie & Powell, 2007) and various
programs from the CCP4 program suite (Winn et al., 2011).
The final statistics of data collection and processing are
summarized in Table 3.
3. Results and discussion
The coding region of sheep galectin-11 was successfully cloned
by ligation-independent cloning and expressed in E. coli strain
BL21 (DE3). The recombinant galectin-11 was purified puri-
fied to homogeneity by two chromatographic steps: nickel-
affinity chromatography and His-tag removal by HRV-3C
protease followed by size-exclusion chromatography. The
major elution volume peak in the gel-filtration column
corresponds to a dimer in solution with an approximate
molecular weight of 30 kDa (Fig. 1a). Purified protein was
analysed by SDS–PAGE (Fig. 1b) and Western blotting to
confirm its identity and purity. This expression and purification
strategy routinely produced yields of 9 mg per litre of culture.
Recombinant galectin-111–140 was successfully eluted from
galactose Sepharose beads by various sugars, suggesting that
recombinant galectin-11 is functional and that the glycan
specificity of galectin-11 may be very broad (Fig. 1b). Crystals
of galectin-1118–140 were initially obtained by the sitting-drop
vapour-diffusion method and were optimized manually using
the hanging-drop vapour-diffusion method. Crystals of
galectin-1118–140 were obtained in many crystallization condi-
tions; however, a complete diffraction data set was collected at
100 K from crystals grown in 2%(v/v) Tacsimate pH 7.0, 0.1M
HEPES–HCl pH 7.3, 14%(w/v) PEG 3350 (Fig. 3). The
diffraction quality of the crystals was strictly dependent on
maintaining the recombinant galectin-11 in a reduced state.
Preliminary crystallographic analysis indicated that the crys-
tals belonged to space group P212121, with unit-cell para-
meters a = 96.2, b = 127.5, c = 141.4 A˚,  = 90.0,  = 90.0,
 = 90.0. Based on Matthews coefficient calculations, 12
molecules of galectin-11 (52% solvent content) could be
accommodated in the asymmetric unit, with an acceptable VM
of around 2.58 A˚3 Da1 (Matthews, 1968). The data-collection
and processing statistics are summarized in Table 3. Structure
determination by means of molecular replacement was
successful using the known structure of human galectin-10
(Charcot–Leyden crystal protein; PDB entry 1g86; Ackerman
et al., 2002), which shares 40% sequence identity with galectin-
11. Structure verification and model rebuilding are currently in
progress, as well as co-crystallization experiments with the
identified sugars.
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